Michael Kalb | executive |
Richard John Daly | executive |
Jeffrey Del Carmen | executive |
Steven Miller | executive |
Jeremy Jacoby | analyst |
Charles Duncan | analyst |
Jason Gerberry | analyst |
Joseph Catanzaro | analyst |
Greetings and welcome to the Catalyst Pharmaceuticals First Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mike Kalb, Chief Financial Officer. Thank you, sir.
You may begin.
Thank you.